NCT06448767View on ClinicalTrials.gov

The Effect of a Multispecies Probiotics on Autism Symptoms and the Quality of Life in Children

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 30, 2026

Conditions
Autism Spectrum Disorder
Interventions
DIETARY_SUPPLEMENT

Multispecies probiotics

Multispecies probiotics consisting of Bacillus subtilis W201, Bifidobacterium infantis W17, Bifidobacterium lactis W51, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus rhamnosus W140, Lactococcus lactis W19, Propionibacterium freudenreichii W200 at a dose of 5x10\^9 Colony Forming Units (CFU), once daily, orally.

OTHER

Placebo

Placebo identical in taste, smell and color to the multispecies probiotics.

Trial Locations (3)

02-091

RECRUITING

Department of Paediatrics, The Medical University of Warsaw, Warsaw

RECRUITING

Department of Paediatrics, The Medical University of Warsaw, Warsaw

RECRUITING

Department of Paediatrics, The Medical University of Warsaw, Warsaw

All Listed Sponsors
collaborator

Winclove Probiotics B.V.

INDUSTRY

lead

Medical University of Warsaw

OTHER